Superworth

Obsidian Therapeutics OBX

Drug Manufacturers - General, Healthcare
$14.43
−2.43%
Market cap
$891.4M
PE
n/m
not a meaningful number
Forward PE
n/m
not a meaningful number
Price to sales
n/m
not a meaningful number
EV/EBIT
n/m
not a meaningful number
Revenue, 12 months
n/m
not a meaningful number
Net margin
n/m
not a meaningful number
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for OBX, by quarter
Income statementQ2 FY26
Net income$0

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Drug Manufacturers - General nearest Obsidian Therapeutics' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
OBXObsidian Therapeutics$891.4Mn/mn/an/mn/mn/m
ABUSArbutus Biopharma$791.4M5.1×5.6×4.4×n/m84.2%
COLLCollegium Pharmaceutical$770.9M19.1×19.1×1.0×+14%5.9%
AMPHAmphastar Pharmaceuticals$1.1B15.9×20.5×1.6×+1%10.8%
OMEROmeros$1.3B11.7×11.7×n/mn/mn/m
ZVRAZevra Therapeutics$599.8M10.9×12.2×4.4×+119%42.8%
IRWDIronwood Pharmaceuticals$571.7M4.5×14.8×1.5×+26%33.4%
ANABAnaptysbio$1.4B10.3×99.3×n/mn/mn/m
PCRXPacira BioSciences$1.5B104×65.7×1.9×+6%2.0%
PBYIPuma Biotechnology$525.5M19.6×12.3×2.3×−3%11.6%
PAHCPhibro Animal Health$1.6B15.9×21.5×1.0×+17%6.6%
Peer median$970.6M13.8×17.0×1.8×+14%11.2%

More on Obsidian Therapeutics

Its groups

About

Industry
Drug Manufacturers - General
Sector
Healthcare

Valuation data, not investment advice. Prices as of .